Published Online: Sunday, July 1, 2007

Advancis Pharmaceutical Corp has changed its corporate name to Middlebrook Pharmaceuticals Inc. The company is the supplier of cephalexin (Keflex) capsules.

MiddleBrook Pharmaceuticals is a company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease.

In May 2007, the FDA accepted for review MiddleBrook?s new drug application for Amoxicillin PULSYS, a once-daily pulsatile-release formulation of amoxicillin for oral administration.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues